# Tolerability of Quinagolide in a Dose-titration Regimen in Oocyte Donors at Risk of Developing Ovarian Hyperstimulation Syndrome

> **NCT00665041** · PHASE2 · COMPLETED · sponsor: **Instituto Valenciano de Infertilidad, IVI VALENCIA** · enrollment: 30 (estimated)

## Conditions studied

- Ovarian Hyperstimulation Syndrome

## Interventions

- **DRUG:** Quinagolide

## Key facts

- **NCT ID:** NCT00665041
- **Lead sponsor:** Instituto Valenciano de Infertilidad, IVI VALENCIA
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-05
- **Primary completion:** 2008-08
- **Final completion:** 2008-10
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2009-09-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00665041

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00665041, "Tolerability of Quinagolide in a Dose-titration Regimen in Oocyte Donors at Risk of Developing Ovarian Hyperstimulation Syndrome". Retrieved via AI Analytics 2026-07-28 from https://api.ai-analytics.org/clinical/NCT00665041. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*